» Articles » PMID: 17504270

Excitotoxic Damage to White Matter

Overview
Journal J Anat
Date 2007 May 17
PMID 17504270
Citations 112
Authors
Affiliations
Soon will be listed here.
Abstract

Glutamate kills neurons by excitotoxicity, which is caused by sustained activation of glutamate receptors. In recent years, it has been shown that glutamate can also be toxic to white matter oligodendrocytes and to myelin by this mechanism. In particular, glutamate receptor-mediated injury to these cells can be triggered by activation of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid, kainate and N-methyl-D-aspartate glutamate receptor types. Thus, these receptor classes, and the intermediaries of the signal cascades they activate, are potential targets for drug development to treat white matter damage in acute and chronic diseases. In addition, alterations of glutamate homeostasis in white matter can determine glutamate injury to oligodendrocytes and myelin. Astrocytes are responsible for most glutamate uptake in synaptic and non-synaptic areas and consequently are the major regulators of glutamate homeostasis. Activated microglia in turn may secrete cytokines and generate radical oxygen species, which impair glutamate uptake and reduce the expression of glutamate transporters. Finally, oligodendrocytes also contribute to glutamate homeostasis. This review aims at summarizing the current knowledge about the mechanisms leading to oligodendrocyte cell death and demyelination as a consequence of alterations in glutamate signalling, and their clinical relevance to disease. In addition, we show evidence that oligodendrocytes can also be killed by ATP acting at P2X receptors. A thorough understanding of how oligodendrocytes and myelin are damaged by excitotoxicity will generate knowledge that can lead to improved therapeutic strategies to protect white matter.

Citing Articles

Genetic Downregulation of GABA Receptors from Oligodendrocyte Precursor Cells Protects Against Demyelination in the Mouse Spinal Cord.

Gobbo D, Rieder P, Fang L, Buttigieg E, Schablowski M, Damo E Cells. 2024; 13(23).

PMID: 39682762 PMC: 11640606. DOI: 10.3390/cells13232014.


Inside help for brain tumors: macrophage-mediated myelin recycling promotes cell state-specific glioblastoma progression.

Pagano Zottola A, Daubon T, Venkataramani V Signal Transduct Target Ther. 2024; 9(1):355.

PMID: 39632801 PMC: 11618411. DOI: 10.1038/s41392-024-02055-0.


Cerebrovascular disease is associated with Alzheimer's plasma biomarker concentrations in adults with Down syndrome.

Edwards N, Lao P, Alshikho M, Ericsson O, Rizvi B, Petersen M Brain Commun. 2024; 6(5):fcae331.

PMID: 39403075 PMC: 11472828. DOI: 10.1093/braincomms/fcae331.


Psychedelics and schizophrenia: a double-edged sword.

Sapienza J, Martini F, Comai S, Cavallaro R, Spangaro M, De Gregorio D Mol Psychiatry. 2024; 30(2):679-692.

PMID: 39294303 DOI: 10.1038/s41380-024-02743-x.


Neuroinflammation and kynurenines in schizophrenia: Impact on cognition depending on cognitive functioning and modulatory properties in relation to cognitive remediation and aerobic exercise.

Sapienza J, Agostoni G, Comai S, Nasini S, DallAcqua S, Sut S Schizophr Res Cogn. 2024; 38:100328.

PMID: 39281320 PMC: 11399803. DOI: 10.1016/j.scog.2024.100328.


References
1.
Petito C, Olarte J, Roberts B, Nowak Jr T, Pulsinelli W . Selective glial vulnerability following transient global ischemia in rat brain. J Neuropathol Exp Neurol. 1998; 57(3):231-8. DOI: 10.1097/00005072-199803000-00004. View

2.
Matute C . Characteristics of acute and chronic kainate excitotoxic damage to the optic nerve. Proc Natl Acad Sci U S A. 1998; 95(17):10229-34. PMC: 21490. DOI: 10.1073/pnas.95.17.10229. View

3.
Ralevic V, Burnstock G . Receptors for purines and pyrimidines. Pharmacol Rev. 1998; 50(3):413-92. View

4.
Barkhatova V, Zavalishin I, Askarova L, Shavratskii V, Demina E . Changes in neurotransmitters in multiple sclerosis. Neurosci Behav Physiol. 1998; 28(4):341-4. DOI: 10.1007/BF02464784. View

5.
Dingledine R, Borges K, Bowie D, Traynelis S . The glutamate receptor ion channels. Pharmacol Rev. 1999; 51(1):7-61. View